Wellcome Trust Centre for Gene Regulation and Expression, and Division of Biological Chemistry and Drug Discovery, College of Life Sciences, University of Dundee, Dow Street, Dundee DD1 5EH, United Kingdom.
Mol Biol Cell. 2010 May 1;21(9):1569-84. doi: 10.1091/mbc.e10-01-0078. Epub 2010 Mar 10.
Human small nucleolar RNAs (snoRNAs) that copurify with nucleoli isolated from HeLa cells have been characterized. Novel fibrillarin-associated snoRNAs were detected that allowed the creation of a new vector system for the targeted knockdown of one or more genes in mammalian cells. The snoMEN (snoRNA modulator of gene expressioN) vector technology is based on snoRNA HBII-180C, which contains an internal sequence that can be manipulated to make it complementary to RNA targets. Gene-specific knockdowns are demonstrated for endogenous cellular proteins and for G/YFP-fusion proteins. Multiplex snoMEN vectors coexpress multiple snoRNAs in one transcript, targeted either to different genes or to different sites in the same gene. Protein replacement snoMEN vectors can express a single transcript combining cDNA for a tagged protein with introns containing cognate snoRNAs targeted to knockdown the endogenous cellular protein. We foresee applications for snoMEN vectors in basic gene expression research, target validation, and gene therapy.
已鉴定出与人小核仁 RNA(snoRNA)与从小鼠 HeLa 细胞分离的核仁共纯化的小核仁 RNA(snoRNA)。检测到新型核仁纤维蛋白相关 snoRNA,可用于创建新的载体系统,在哺乳动物细胞中靶向敲低一个或多个基因。 snoMEN( snoRNA 基因表达调节剂)载体技术基于 snoRNA HBII-180C,其包含可被操纵以使其与 RNA 靶标互补的内部序列。针对内源性细胞蛋白和 G/YFP-融合蛋白进行了基因特异性敲低。多plex snoMEN 载体在一个转录本中共同表达多个 snoRNA,靶向不同的基因或同一基因中的不同位点。蛋白替换 snoMEN 载体可以表达单个转录本,该转录本将标记蛋白的 cDNA 与包含针对内源性细胞蛋白进行敲低的同源 snoRNA 的内含子结合在一起。我们预见 snoMEN 载体在基础基因表达研究、靶标验证和基因治疗中的应用。